Bristol Myers Squibb Company (BMY)

Last Price: 59.43 (2020-07-01)

Company Description

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $26.14B
Net Income (Most Recent Fiscal Year) $3.44B
PE Ratio (Current Year Earnings Estimate) 9.54
PE Ratio (Trailing 12 Months) 11.11
PEG Ratio (Long Term Growth Estimate) 1.14
Price to Sales Ratio (Trailing 12 Months) 4.29
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.66
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 13.39
Pre-Tax Margin (Trailing 12 Months) 8.68%
Net Margin (Trailing 12 Months) 3.08%
Return on Equity (Trailing 12 Months) 30.06%
Return on Assets (Trailing 12 Months) 10.96%
Current Ratio (Most Recent Fiscal Quarter) 1.66
Quick Ratio (Most Recent Fiscal Quarter) 1.51
Debt to Common Equity (Most Recent Fiscal Quarter) 0.86
Inventory Turnover (Trailing 12 Months) 4.12
Book Value per Share (Most Recent Fiscal Quarter) $23.20
Earnings per Share (Most Recent Fiscal Quarter) $1.72
Earnings per Share (Most Recent Fiscal Year) $4.69
Diluted Earnings per Share (Trailing 12 Months) $0.81
Stock
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 2.26B
Free Float 2.26B
Market Capitalization $133.05B
Average Volume (Last 20 Days) 16.92M
Beta (Past 60 Months) 0.73
Percentage Held By Insiders (Latest Annual Proxy Report) 0.14%
Percentage Held By Institutions (Latest 13F Reports) 74.17%
Annual Dividend (Based on Last Quarter) $1.80
Dividend Yield (Based on Last Quarter) 3.06%